Complete immune and clinical recovery after highly active antiretroviral therapy in advanced vertically HIV-1 infected children;Reconstitución clínica e inmunológica completa tras el tratamiento antirretroviral de gran actividad en un niño infectado verticalmente por el virus de la inmunodeficiencia humana tipo 1 con enfermedad avanzada

Medicina Clinica

Volumn 120, Issue 11, 2003, Pages 417-420

  Resino, Salvador ^a   Sánchez Ramón, Silvia ^a   Correa, Rafael ^a   Navarro, M Luisa ^a   Bellón, José M ^a   Muñoz Fernández, M Ángeles ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Children; Cytokine; HAART; HIV 1; Proliferation; T cell subsets; TRECs; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; CELL MARKER; CYTOKINE; DIDANOSINE; EFAVIRENZ; GAMMA INTERFERON; INTERLEUKIN 5; LAMIVUDINE; NELFINAVIR; STAVUDINE; THYMIDINE; TRITIUM; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CELL CULTURE; CHILD; CONTROLLED STUDY; CONVALESCENCE; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE REARRANGEMENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNE SYSTEM; ISOTOPE LABELING; LONG TERM CARE; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MEMORY CELL; NONHUMAN; PATIENT MONITORING; PERIPHERAL LYMPHOCYTE; QUANTITATIVE ANALYSIS; SYMPTOMATOLOGY; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; THYMUS FUNCTION; TREATMENT OUTCOME; VERTICAL TRANSMISSION; VIRUS DETECTION; VIRUS LOAD;

EID: 0242585493     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13045309     Document Type: Article

References (27)

1. Chavan S, Bennuri B, Kharbanda M, Chandrasekaran A, Bakshi S, Phawa S. Evaluation of T cell receptor gene rearrangement excision circles after antiretroviral therapy in children infected with human immunodeficiency virus. J Infect Dis 2001;183:1445-54.
2. Essajee SM, Kim M, González C, Rigaud M, Kaul A, Chandwani S, et al. Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children. AIDS 1999;13:2523-32.
3. Chougnet C, Jankelevich S, Fowke K, Liewehr D, Steinberg SM, Mueller BU, et al. Long-term protease inhibitor-containing therapy results in limited improvement in T cell function but not restoration of interleukin-12 production in pediatrics patients with aids. J Infect Dis 2001;184:201-5.
4. Angel JB, Parato KG, Kumar A, Kravcik S, Badley AD, Fex C, et al. Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression. J Infect Dis 2001;183:546-54.
5. Gea-Banacloche JC, Clifford Lane H. Immune reconstitution in HIV infection. AIDS 1999;13: S25-S38.
6. Pakker NG, Notermans DW, De Boer RJ, Roos MT, De Wolf F, Hill A, et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med 1998;4:208-14.
7. Correa R, Muñoz-Fernández MA. Effect of HAART on thymic reconstitution of CD4 T lymphocytes in vertically HIV-infected children. AIDS 2002;16:1181-3.
8. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey Jm, Haynes BF, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998;396:690-5.
9. Mintz M. Micronutrient and cytokine interaction in congenital pediatric HIV infection. J Nutr 1996;126:2674S-9S.
10. Miller TL, Mawn BE, Orav EJ, Milk D, Weingerg GA, Nicchitta J, et al. The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type 1-infected children. Pediatrics 2001;107:E77.
11. Moyer J Jr, Rich KC, Kalish LA, Sheon AR, Díaz C, Cooper ER, et al. Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmissions Study Group. J Ark Med Soc 1996;92:407.
12. Mueller BU, Sleasman J, Nelson RP Jr, Smith S, Deutsch PJ, JU W, et al. A phase I/II study of the protease inhibitor indinavir in children with HIV infection. Pediatrics 1998;102:e8.
13. Muñoz-Fernández MA, Obregón E, Navarro J, Borner C, Gurbindo MD, Sampelayo TH, et al. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection. Pediatr Res 1996;40:597-602.
14. Correa R, Muñoz-Fernández MA. Viral phenotype affects the thymical production of new T-cells in HIV-1 infected children. AIDS 2001;15:1959-63.
15. Resino S, Correa R, Bellón J, Sánchez-Ramón S, Muñoz-Fernández M. Characterizing immune reconstitution after long-term HAART in pediatric AIDS. AIDS Res Hum Retrovir 2002;18: 1395-406.
16. Resino S, Abad M, Bellón JM, Gurbindo M, León J, Muñoz-Fernández MA. Variación del perfil inmunológico en función de la progresión de la infección por el virus de la inmunodeficiencia humana en niños tratados con terapia, antirretroviral. Med Clin (Barc) 2002; 118:241-6.
17. Sánchez E, Hernández M, Sobradillo B. Examen clínico antropométrico en la valoración del estado nutricional infantil. Milupa, Actualidad Nutricional 1991;6:8-16
18. CDCP. Center for Diseases Control Prevention. Revised classification system for HIV-1 infection in children less than 13 years of age MMWR 1994;43:1-13.
19. Resino S, Bellón JM, Sánchez-Ramón S, Gurbindo D, Ruiz-Contreras J, León JA, et al. Impact of antiretroviral protocols on dynamics of AIDS progression markers. Arch Dis Child 2002;86:119-24.
20. Resino S, Sánchez-Ramón S, Bellón JM, Correa R, Abad ML, Muñoz-Fernández MA. Immunological recovery after 3 year's antiretroviral therapy in HIV-1-infected children. AIDS 2002;16:483-6.
21. Powderly WG, Landay A, Lederman MM. Recovery of the immune system with antiretroviral therapy: the end of opportunism? JAMA 1998; 280:72-7.
22. Resino S, Bellón JM, Gurbindo D, Muñoz-Fernández MA. Dysruption in cytokine and chemokine production by T cells in vertically HIV-1 infected children. Acta Pediatrica 2001;90: 989-97.
23. Imami N, Antonopoulos C, Hardy GA, Gazzard B, Gotch FM. Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: impact of highly active antiretroviral therapy. AIDS Res Hum Retrovirus 1999;15:1499-508.
24. Ambinder RF. Epstein-Barr virus associated lymphoproliferations in the AIDS setting. Eur J Cancer 2001;37:1209-16.
25. Granovsky MO, Mueller BU, Nicholson HS, Rosenberg PS, Rabkin CS. Cancer in human immunodeficiency virus-infected children: a case series from the Children's Cancer Group and the National Cancer Institute. J Clin Oncol 1998;16: 1729-35.
26. Grabar S, Le Moing V, Goujard C, Leport C, Kazatchkine MD, Costagliola D, et al. Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Ann Intern Med 2000;133:401-10.
27. Rutstein RM, Feingold A, Meislich D, Word B, Rudy B. Protease inhibitor therapy in children with perinatally acquired HIV infection. AIDS 1997;11:1487-94.